| Date Filed | Type | Description |
| 03/06/2023 |
4
| QUAY STEVEN C (President & CEO) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 1,873,100 options to buy
@ $0.72, valued at
$1.3M
|
|
| 02/28/2022 |
4
| QUAY STEVEN C (President & CEO) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 1,900,000 options to buy
@ $1.25, valued at
$2.4M
|
|
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/13/2020 |
4
| QUAY STEVEN C (President & CEO) has filed a Form 4 on ATOSSA THERAPEUTICS, INC.|
Txns:
| Granted 195,000 options to buy
@ $1.48, valued at
$288.6k
Granted 1,305,000 options to buy
@ $1.48, valued at
$1.9M
|
|
| 01/15/2019 |
4
| QUAY STEVEN C (President & CEO) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Disposed/sold 2,300,000 options to buy
@ $2.38, valued at
$5.5M
Granted 2,300,000 options to buy
@ $1.36, valued at
$3.1M
|
|
| 06/29/2018 |
4
| QUAY STEVEN C (President & CEO) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 2,300,000 options to buy
@ $2.38, valued at
$5.5M
|
|
| 05/31/2018 |
4
| QUAY STEVEN C (President & CEO) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Bought 8 convertible preferred
@ $1000, valued at
$8k
Bought 2,272 warrants
@ $4.05, valued at
$9.2k
|
|
| 05/26/2017 |
4
| QUAY STEVEN C (President & CEO) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 575,893 options to buy
@ $0.47, valued at
$270.7k
|
|
| 05/19/2016 |
4
| QUAY STEVEN C (President & CEO) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 569,194 options to buy
@ $0.263, valued at
$149.7k
|
|
| 03/10/2016 |
4
| QUAY STEVEN C (President & CEO) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Bought 15,000 shares
@ $0.37, valued at
$5.6k
|
|
| 02/17/2016 |
4
| QUAY STEVEN C (President & CEO) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Bought 15,000 shares
@ $0.53, valued at
$8k
|
|
| 01/27/2016 |
SC 13D/A
| QUAY STEVEN C reports a 16.4% stake in Atossa Genetics Inc. |
| 01/21/2016 |
4
| QUAY STEVEN C (President & CEO) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Bought 50,000 shares
@ $0.2, valued at
$10k
|
|
| 03/18/2015 |
4
| QUAY STEVEN C (President and CEO) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 275,000 options
@ $1.88, valued at
$517k
|
|
| 05/08/2014 |
4
| QUAY STEVEN C (CEO) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 250,000 options to buy
@ $1.22, valued at
$305k
|
|
| 10/03/2013 |
4
| QUAY STEVEN C (CEO) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Sold 7,265 shares
@ $5.658, valued at
$41.1k
|
|
| 03/13/2013 |
4
| QUAY STEVEN C (CEO) has filed a Form 4 on ATOSSA GENETICS INC|
Txns:
| Granted 44,194 options to buy
@ $6.57, valued at
$290.4k
|
|
| 11/15/2012 |
SC 13D
| QUAY STEVEN C reports a 37.6% stake in Atossa Genetics Inc. |
| 11/07/2012 |
3
| QUAY STEVEN C (CEO) has filed a Form 3 on ATOSSA GENETICS INC |
| 03/20/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/17/2006 |
5/A
| Form 5/A -- Annual statement of changes in beneficial ownership of securities [amend] |
| 01/03/2006 |
5
| QUAY STEVEN C (Chairman, President and CEO) has filed a Form 5 on NASTECH PHARMACEUTICAL CO INC |
| 02/13/1998 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/20/1997 |
SC 13G/A
| QUAY STEVEN C reports a 18% stake in SONUS PHARMACEUTICALS, INC. |